THE PRESENCE OF M2 MACROPHAGES IN OVARIAN CANCER IS INFLUENCED BY TUMOR STAGE AND GRADE, NOT BY THE ADMINISTRATION OF PACLITAXEL-CARBOPLATIN: A PILOT STUDY

被引：0
|
作者：
Baert, T. [1 ]
Mathivet, T. [2 ]
Van Hoylandt, A. [3 ]
Vergote, I. [1 ]
Coosemans, A. [1 ]
机构：
[1] Univ Hosp Leuven, Gynaecol & Obstet, Leuven, Belgium
[2] Katholieke Univ Leuven, Vesalius Res Ctr, Dept Oncol, Lab Vasc Patterning, Leuven, Belgium
[3] Katholieke Univ Leuven, Dept Oncol, Lab Gynaecol Oncol, Leuven, Belgium
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-1130
引用
收藏
页码：1282 / 1282
页数：1
相关论文
共 50 条
  • [21] Dose-dense chemotherapy with paclitaxel and carboplatin in stage III-IV ovarian cancer:: Pathologic response and outcome of pilot study.
    Viret, F
    Bertucci, F
    Houvenaeghel, G
    Gravis, G
    Camerlo, J
    Capiello, M
    Genre, D
    Oziel-Taïeb, S
    Maraninchi, D
    Viens, P
    ANNALS OF ONCOLOGY, 2000, 11 : 86 - 86
  • [22] Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study
    Bolis, Giorgio
    Scarfone, Giovanna
    Raspagliesi, Francesco
    Mangili, Giorgia
    Danese, Saverio
    Scollo, Paolo
    Lo Russo, Domenica
    Villa, Antonella
    Aimone, Paola Daniela
    Scambia, Giovanni
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (16) : 2905 - 2912
  • [23] A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
    Zhang, Meiying
    He, Yifeng
    Sun, Xiangjun
    Li, Qing
    Wang, Wenjing
    Zhao, Aimin
    Di, Wen
    JOURNAL OF OVARIAN RESEARCH, 2014, 7
  • [24] A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
    Meiying Zhang
    Yifeng He
    Xiangjun Sun
    Qing Li
    Wenjing Wang
    Aimin Zhao
    Wen Di
    Journal of Ovarian Research, 7
  • [25] Paclitaxel (175 mg/m2) plus carboplatin verses paclitaxel (225 mg/m2) plus carboplatin in inoperable non-small cell lung cancer:: A randomized trial of the Hellenic cooperative oncology group
    Kosmidis, P
    Mylonakis, N
    Skarlos, D
    Samantas, E
    Demopoulos, M
    Papadimitriou, C
    Kalophonos, C
    Pavlidis, N
    Papakonstantinou, C
    Fountzilas, G
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 73 - 73
  • [26] Role and presence of cancer associated fibroblasts and M2 macrophages in high grade cervical intraepithelial neoplasia and invasive cervical carcinomas
    Maldonado, Leonel
    Diaz-Montes, Teresa
    Sinno, Abdulrahman
    Tanner, Edward J.
    VandenBussche, Christopher
    Roden, Richard
    Yotova, Iveta
    Tycko, Benjamin
    Trimble, Cornelia L.
    CANCER RESEARCH, 2014, 74 (19)
  • [27] APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer
    Yang, Shimin
    Du, Jingxiao
    Wang, Wei
    Zhou, Dongmei
    Xi, Xiaowei
    BMC CANCER, 2024, 24 (01)
  • [28] APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer
    Shimin Yang
    Jingxiao Du
    Wei Wang
    Dongmei Zhou
    Xiaowei Xi
    BMC Cancer, 24
  • [29] Ovarian cancer stem-like cells elicit the polarization of M2 macrophages
    Zhang, Qing
    Cai, Da-Jun
    Li, Bin
    MOLECULAR MEDICINE REPORTS, 2015, 11 (06) : 4685 - 4693
  • [30] A multicenter randomized phase III study of paclitaxel (175 mg/m2) plus carboplatin (AUC 6) versus paclitaxel (225 mg/m2) plus carboplatin (AUC 6) in advanced non-small cell lung cancer (NSCLC)
    Skarlos, DV
    Mylonakis, N
    Fountzilas, G
    Samantas, E
    Dimopoulos, MA
    Papadimitriou, C
    Kalofonos, H
    Pavlidis, N
    Papakonstantinou, C
    Kosmidis, P
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 25 - 25
12345